<DOC>
	<DOCNO>NCT01750684</DOCNO>
	<brief_summary>To determine safety tolerability AC105 follow regimen 6 intravenous dos 30 hour patient acute non-penetrating traumatic spinal cord injury ( SCI ) .</brief_summary>
	<brief_title>A Study AC105 Patients With Acute Traumatic Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Male female 18 65 year age , inclusive Acute traumatic SCI , neurological level C4 T11 No evidence penetrate transection injury ( e.g . cause projectile stab wound ) Neurological ASIA Impairment Scale A , B C Patient able provide write verbal witnessed consent . If unable provide either , consent may provide legally authorize representative ( LAR ) Patient able initiate treatment within time window injury Known allergy hypersensitivity polyethylene glycol Mental impairment condition would preclude reliable ASIA exam adequate consent Positive urine pregnancy test result Serum creatinine level â‰¥ 2 mg/dL History active renal failure dialysis Mean arterial blood pressure &lt; 60 mmHg despite vasopressor treatment On current regimen digoxin Chronic use magnesium salt prior SCI ( within 1week presentation ) and/or use magnesium salt acute care set prior administration investigational product Any medical condition , judgment investigator , would preclude provision inform consent , make participation study unsafe , unreasonably complicate followup interpretation study outcome data may otherwise interfere achieve study objective In judgment Investigator , adequately provide informed consent , likely noncompliant , may unable cooperate study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Acute</keyword>
	<keyword>Traumatic</keyword>
	<keyword>SCI</keyword>
	<keyword>Spinal Cord Injury</keyword>
</DOC>